Arrhythmia Monitoring Devices Market Size Worth USD 15.33 Billion in 2032 | Emergen Research
15 janv. 2024 07h33 HE
|
Emergen Research
Vancouver, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The global arrhythmia monitoring devices market size was USD 7.43 billion in 2022 and is expected to register a rapid revenue CAGR of 7.7% during the...
Global $12.07 Bn Atrial Fibrillation Markets, 2017-2022, 2022-2027F, 2032F: Analysis, Forecasts and Competitive Landscape
26 oct. 2023 04h18 HE
|
Research and Markets
Dublin, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The "Atrial Fibrillation Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global atrial fibrillation market is...
Defibrillators Market to cross USD 22.5 billion by 2032, says Global Market Insights Inc.
03 avr. 2023 04h10 HE
|
Global Market Insights Inc.
Selbyville, Delaware, April 03, 2023 (GLOBE NEWSWIRE) -- Defibrillators market value is predicted to reach USD 22.5 billion by 2032, as per a new research report announced by Global Market...
Cardiac Ablation Market Trends 2022 | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
02 mars 2022 07h00 HE
|
Graphical Research
Pune, India, March 02, 2022 (GLOBE NEWSWIRE) -- The global cardiac ablation market size is projected to show tremendous growth during the forecast timeframe, owing to the several regions the world...
Cardiac Arrhythmia Monitoring Devices Market to hit $8 billion by 2025: Global Market Insights, Inc.
24 juil. 2019 06h30 HE
|
Global Market Insights, Inc
Selbyville, Delaware, July 24, 2019 (GLOBE NEWSWIRE) -- U.S. cardiac arrhythmia monitoring devices market held 37% revenue share of the global market in 2018. As per the Centers For Diseases...
BioSig Completes Successful Patient Cases at Greenville Memorial Hospital
16 avr. 2019 07h52 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, April 16, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
JACC: Clinical Electrophysiology Manuscript Featuring BioSig’s PURE EP System in Top Five Most Influential of 2016
21 févr. 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, Feb. 21, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to...